ALLIANCE HEALTHCARE SERVICES, INC. (NASDAQ:AIQ) Files An 8-K Termination of a Material Definitive Agreement
Item 1.02. Termination of a Material Definitive Agreement.

In connection with the Merger (as defined below), on August21, 2017, Alliance HealthCare Services, Inc. (the “Company”), Tahoe Investment Group Co., Ltd., an entity organized under the laws of the People’s Republic of China (formerly known as Fujian Thai Hot Investment Co., Ltd., “Tahoe”) and THAIHOT Investment Company Limited, an exempted company incorporated under the laws of the Cayman Islands and an indirect wholly owned subsidiary of Tahoe (“THAIHOT”) entered into a Termination Agreement (the “Termination Agreement”), which, effective immediately following the effective time of the Merger, terminated that certain Governance, Voting and Standstill Agreement, dated March29, 2016, by and among the Company, THAIHOT and Tahoe.

The foregoing description of the Termination Agreement does not purport to be complete and is subject, and qualified in its entirety by reference, to the full text of the Termination Agreement, which is included as Exhibit 10.1 hereto and incorporated herein by reference.

The information set forth in Item 1.02 is incorporated herein by reference.

On August21, 2017, the Company completed the previously announced merger (the “Merger”) of Alliance Healthcare Services Merger Sub Limited, a Delaware corporation (“Sub”), with and into the Company, whereby the Company became a wholly owned subsidiary of THAIHOT Investment Company US Limited, a Delaware corporation and an indirect wholly owned subsidiary of Tahoe (“Parent”). The Merger was effected to the terms of an Agreement and Plan of Merger, dated as of April10, 2017 (the “Merger Agreement”), by and among the Company, Tahoe, THAIHOT, Parent and Sub. Tahoe, THAIHOT Parent and Sub are collectively referred to as the “Purchaser Parties.”

At the effective time of the Merger, each share of common stock of the Company, par value $0.01 per share (the “Common Stock”), issued and outstanding immediately prior to the effective time of the Merger (other than shares beneficially owned by the Purchaser Parties or any of their affiliates (the “Purchaser Group”), shares owned by the Company as treasury stock, and shares owned by holders of Common Stock who shall neither have voted in favor of the Merger nor consented thereto in writing and who shall have properly and validly perfected, and not effectively withdrawn or lost their statutory appraisal rights under Delaware law (such shares of Common Stock, “dissenting shares”) was converted into the right to receive $13.25 in cash, without interest and less any applicable withholding taxes (the “Merger Consideration”).

The Merger was consummated following the approval and adoption of the Merger Agreement by the holders of (a)a majority of the aggregate voting power of the issued and outstanding shares of Common Stock and (b)a majority of the outstanding shares of Common Stock not beneficially owned by the Purchaser Group or any officer of the Company (determined to Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)).

The total amount of funds required to complete the Merger, including payment of the aggregate Merger Consideration and related fees and expenses, was approximately $75million, which the Purchaser Parties funded from cash on hand.

The description of the Merger Agreement and related transactions in this current report on Form 8-K does not purport to be complete and is subject, and qualified in its entirety by reference, to the full text of the Merger Agreement, which is included as Exhibit2.1 hereto and incorporated herein by reference.

On August21, 2017, the Company notified NASDAQ of the completion of the Merger and requested that trading in Common Stock be suspended and that NASDAQ file with the SEC a Notification of Removal from Listing and/or Registration under Section12(b) of the Exchange Act, on Form 25, thereby commencing the process of delisting and deregistering the Common Stock. The Company intends to file a Form 15 to suspend its reporting obligations under Section15(d) of the Exchange Act and to deregister its Common Stock under Section12(g) of the Exchange Act.

The information set forth in Item 1.02 is incorporated herein by reference.

Upon completion of the Merger, each share of Common Stock issued and outstanding immediately prior to the effective time of the Merger (other than shares beneficially owned by the Purchaser Group, shares owned by the Company as treasury stock and dissenting shares) was converted into the right to receive the Merger Consideration, and such stockholders of the Company ceased to have any rights as stockholders of the Company (other than their right to receive the Merger Consideration).

The information set forth in Items 2.01, 3.01, 5.03 is incorporated herein by reference.

2

Item 1.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Upon completion of the Merger on August21, 2017, in accordance with the Merger Agreement, the members of the Sub’s board of directors immediately before the Merger, Qisen Huang and Yong Ge, became the members of the Company’s board of directors. Accordingly, each of Larry C. Buckelew, Scott A. Bartos, Neil F. Dimick, Heping Feng, Edward L. Samek, Percy C. Tomlinson, Paul S. Viviano and Tao Zhang ceased serving as members of the Company’s board of directors at the effective time of the Merger. These departures were solely in connection with the Merger and not a result of any disagreement with the Company, its management or its board of directors.

The information set forth in Item 1.02 is incorporated herein by reference.

to the Merger Agreement, the certificate of incorporation of Sub as in effect immediately prior to the effective time of the Merger became the certificate of incorporation of the Company and the bylaws of Sub as in effect immediately prior to the effective time of the Merger became the bylaws of the Company. The certificate of incorporation and the bylaws of the Company as so amended are attached as Exhibits 3.1 and 3.2 hereto, respectively, and incorporated herein by reference.

The following exhibits are filed with this Form 8-K:

3

Alliance HealthCare Services, Inc Exhibit
EX-10.1 2 d436846dex101.htm EX-10.1 EX-10.1 Exhibit 10.1 TERMINATION AGREEMENT This TERMINATION AGREEMENT (this “Termination Agreement”),…
To view the full exhibit click here

About ALLIANCE HEALTHCARE SERVICES, INC. (NASDAQ:AIQ)

Alliance HealthCare Services, Inc. (Alliance) is a provider of outsourced healthcare services to hospitals and providers. The Company operates through three segments: Radiology Division, Oncology Division and Interventional Healthcare Services Division. The radiology segment comprises diagnostic imaging services, including magnetic resonance imaging (MRI), positron emission tomography/computed tomography (PET/CT) and other imaging services. The radiology segment also comprises radiation oncology services. The interventional healthcare services segment provides interventional healthcare through therapeutic minimally invasive pain management procedures medical management, laboratory testing and other services. The Company operates freestanding outpatient radiology, oncology and interventional clinics, and Ambulatory Surgical Centers (ASC) that are not owned by hospitals or providers. It operates over 560 diagnostic imaging and radiation therapy systems.